Today’s Top Story

 

Study: Vulnerable Healthcare Markets Less Likely to Have High-performing Joint Replacement Hospitals

 

A cross-sectional study in the Journal of the AAOS® examined healthcare market- and hospital-level disparities in access to high-quality hip/knee replacement hospitals. A total of 2,682 hospitals and 304 healthcare markets were identified via 2021 Centers for Medicare & Medicaid Services (CMS) outcome measures and the 2022 Joint Commission (JC) process-of-care measures. Hospitals in the top quartile for low-income patient loads were less likely to be designated by CMS as “better than the national average” but were not more or less likely to be certified as “advanced” by the JC. Additionally, vulnerable healthcare markets had lower odds of having high-performing hip/knee hospitals.
Read the abstract…

 

In Other News

 

Revision Hip Arthroscopy Results in Similar Survivability but Worse Outcomes versus Primary Arthroscopy

 

Arthroscopy published a study comparing the clinical outcomes of patients with femoroacetabular impingement undergoing primary hip arthroscopy (HA) versus revision HA (RHA). Fifty-one RHA patients were propensity matched in a 1:4 ratio to 204 HA patients. Hip Outcome Score Sports subscale (HOS-SS), modified Harris Hip Score (mHHS), and international Hip Outcome Tool (iHOT-12) scores were compared between groups. There were no significant differences regarding the rates of conversion to total hip arthroplasty or reoperation. RHA patients had significantly lower HOS-SS (64.9 versus 75.3), mHHS (72.2 versus 80.1), and iHOT-12 (61.4 versus 71) scores.

 

Read the abstract…

 

Does an Anterior Intrapelvic Approach Affect Blood Loss during Early Treatment of Acetabular Fractures?

 

The Journal of Orthopaedic Trauma published a retrospective study investigating whether time from hospital admission to surgery for acetabular fractures using an anterior intrapelvic approach affects blood loss. Estimated blood loss, calculated blood loss, and packed red blood cell (PRBC) transfusion requirements were used to evaluate blood loss in 195 patients. Patients who underwent surgery <48 hours after admission had significantly greater blood loss (453 mL versus 364 mL); however, there were no significant differences observed in terms of PRBC transfusion.
Read the abstract…

 

Study Finds Orthopaedic Specialty Hospitals Are Optimized for CMS Payments

 

According to a study in Current Orthopaedic Practice, orthopaedic specialty hospitals (OSHs) performed major joint/limb reattachment procedures of upper extremities (diagnosis-related group 483 [DRG-483]) at a 15 percent lower average Medicare payment (AMP) than nonspecialty hospitals (NSHs). To examine the cost-effectiveness of upper extremity arthroplasties at OSHs, CMS inpatient charge data on DRG-483 procedures and the influence of volume, hospital demographics, and orthopaedic specialization was analyzed. DRG-483 volume was weakly negatively correlated with AMP, and metropolitan centers performed DRG-483 procedures at the lowest cost to the Centers for Medicare & Medicaid Services (CMS).
Read the study…

 

Study: 3D-printed Pedicle Screw Guides Associated with Reduced Intraoperative Revision Rate

 

The Spine Journal published a retrospective study that found pedicle screw fixation utilizing 3D-printed guides reduced intraoperative revision rates compared with freehand techniques during adolescent idiopathic scoliosis surgery. Seventeen and 15 patients were in the 3D-guided and fluoroscopy-guided freehand cohorts, respectively. The revision rate of pedicle screws and operative times were compared between cohorts. The overall revision rate for 3D-guided screw placement was 5.5 percent, compared with 8.5 percent for the freehand technique. There were no significant differences in number of levels fused or surgical time between groups.

 

Read the abstract…

AAOS Now

 

Cato T. Laurencin, MD, PhD, Brings Science, Engineering, and Medicine to Higher Levels with Establishment of New Institute for Regenerative Engineering

 

The University of Connecticut has recently launched the Cato T. Laurencin Institute for Regenerative Engineering, a groundbreaking initiative aimed at advancing the fields of medicine, science, engineering, and technology. This institute is a testament to Cato T. Laurencin, MD, PhD, FAAOS, and his exceptional contributions to musculoskeletal regenerative engineering, dedication to promoting diversity in orthopaedics, and visionary goal of achieving limb regeneration.
Read more…

 

Your AAOS

 

Take Part in a Clinical Practice Guideline Review Period

 

AAOS has completed the development of two clinical practice guidelines (Management of Carpal Tunnel Syndrome and Management of Osteoarthritis of the Hip) and is now seeking volunteers to review the manuscript drafts prior to their approval and publication. Taking part in the review period gives members who were not involved in the development process an opportunity to provide feedback. The deadline to apply is Sept. 1.

 

Apply to review the Management of Carpal Tunnel Syndrome guideline…
Apply to review the Management of Osteoarthritis of the Hip guideline…

 

AAOS Headline News Now (HNN) is a twice-weekly member service produced by the AAOS Now editorial staff.

Disclaimer: AAOS is not responsible for the privacy policy, the content, or the accuracy of any website accessed through a link in HNN or the AAOS website. Links to other websites do not constitute as an endorsement by AAOS of the linked site, its products, or services. Content, conclusions or opinions expressed in any article are not necessarily those of the AAOS. Please direct feedback to headlinenewsnow@aaos.org.

 

 

 

Download the Membership App

 

View in Browser

 

Manage My Communication Preferences

Privacy Policy  |  Contact Us

 

This email was sent to wvos@frontier.com.

 

American Academy of Orthopaedic Surgeons

9400 W Higgins Rd, Rosemont, Illinois, 60018

(847) 823-7186 | (800) 626-6726

 

American Association of Orthopaedic Surgeons

317 Massachusetts Ave, NE, STE 100, Washington, DC, 20002

(202) 546-4430